Date: 24.6.2011
A study conducted by researchers at Karolinska Institutet's Department of Molecular Medicine and Surgery presents a possible method of delaying the disease.
Type I diabetes coincides with high blood concentrations of the lipoprotein apolipoprotein CIII (ApoCIII). The team has now demonstrated on rats, which develop a form of type I diabetes analogous to the human kind, that levels of Apo CIII are raised before the onset of the disease and that this causes the insulin producing beta cells to die.
By reducing the production of ApoCIII using antisense therapy, the researchers succeeded in significantly delaying the onset of diabetes to the extent that it took twice as long for the rats to develop the disease.
Source:
http://ki.se/ki/jsp/polopoly.jsp?d=130&a=124361&l=en&newsdep=130
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Brno University of Technology - university of technology in Brno
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Mussel-inspired adhesive builds a bond between implants and bones
Newly identified algal strains rich in phosphorus could improve wastewater treatment